Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 1, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	48	15	13	16	193	-
Market Cap Growth	222.30%	16.02%	-17.63%	-91.70%	-	-
Enterprise Value	49	15	9	15	192	-
Last Close Price	0.24	0.08	0.11	0.17	2.03	-
PS Ratio	19.86	11.92	49.15	15.92	178.32	-
PB Ratio	11.05	1.91	1.48	0.88	7.38	-
P/TBV Ratio	15.35	2.31	1.48	1.38	9.80	-
EV/Sales Ratio	20.26	12.02	33.94	15.12	177.78	-
Debt / Equity Ratio	0.46	0.28	0.01	0.03	-	-
Asset Turnover	0.21	0.12	0.02	-	0.05	-
Quick Ratio	0.55	0.55	4.01	4.03	4.70	44.80
Current Ratio	0.75	0.72	4.12	4.13	18.88	44.80
Return on Equity (ROE)	-187.76%	-96.11%	-32.03%	-	-58.29%	-
Return on Assets (ROA)	-24.06%	-15.98%	-5.25%	-	-8.78%	-
Return on Capital (ROIC)	-25.91%	-18.27%	-5.69%	-	-14.18%	-
Earnings Yield	-38.77%	-55.99%	-73.86%	-46.98%	-4.29%	-
Buyback Yield / Dilution	-65.65%	-47.33%	-17.06%	-34.20%	-117.64%	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.